APA (7th ed.) Citation

Pfeuffer, S., Ruck, T., Pul, R., Rolfes, L., Korsukewitz, C., Pawlitzki, M., . . . Meuth, S. (2021). Impact of previous disease-modifying treatment on effectiveness and safety outcomes, among patients with multiple sclerosis treated with alemtuzumab. Journal of neurology, neurosurgery, and psychiatry, 92(9), . https://doi.org/10.1136/jnnp-2020-325304

Chicago Style (17th ed.) Citation

Pfeuffer, Steffen, et al. "Impact of Previous Disease-modifying Treatment on Effectiveness and Safety Outcomes, Among Patients with Multiple Sclerosis Treated with Alemtuzumab." Journal of Neurology, Neurosurgery, and Psychiatry 92, no. 9 (2021). https://doi.org/10.1136/jnnp-2020-325304.

MLA (9th ed.) Citation

Pfeuffer, Steffen, et al. "Impact of Previous Disease-modifying Treatment on Effectiveness and Safety Outcomes, Among Patients with Multiple Sclerosis Treated with Alemtuzumab." Journal of Neurology, Neurosurgery, and Psychiatry, vol. 92, no. 9, 2021, https://doi.org/10.1136/jnnp-2020-325304.